Parasites in pets pose more than just discomfort-they present serious health risks and are highly prevalent in cats across ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to recover with a few proven lifestyle changes.

An inhaled gene therapy for cystic fibrosis developed by Boehringer Ingelheim is due to start clinical testing shortly, hoping to become a first-in-class treatment for the genetic disorder.

Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...

The NIH has lost two distinguished leaders as mass layoffs directed by the Trump administration hit federal health agencies.

An intron is a non-coding section of DNA or RNA within a gene that is removed during protein synthesis. ExpressionEdits is using introns – which had generally been derided as of no value – to enhance ...

Boehringer Ingelheim, the UK Respiratory Gene Therapy Consortium (GTC), IP Group and Oxford BioMedica (OXB) have commenced ...

Eleva, a pioneer in unlocking difficult-to-produce biologics based on a breakthrough moss-based platform, announced today the appointment of Dr. Martin Bauer, MD, as new Chief Medical Officer. His ...

The oncology testing specialist reported strong top-line growth, but also rising costs and ongoing net losses.

DelveInsight's Influenza Vaccine Market Insights report provides the current and forecast market analysis, individual leading ...

Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.